LANCASTER, Calif.--(BUSINESS WIRE)--Simulations Plus, Inc. (NASDAQ: SLP), a leading provider of simulation and modeling software to the pharmaceutical industry, announces the release of DDDPlus 3.0, a major update to its unique software that simulates in vitro dissolution experiments to assist pharmaceutical formulation scientists in the design of new dosage forms and new experimental conditions.
